PRECISION BIOSCIENCES INC Lessee, Operating Lease, Liability, to be Paid, Year One
PRECISION BIOSCIENCES INC (DTIL) had Lessee, Operating Lease, Liability, to be Paid, Year One of $2.08 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-06
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $2.08M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $2.08M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $2.02M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $2.02M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $2.08M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $2.08M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $2.02M 10-K · filed 2026-03-12 |
| 2025-09-30 | $2.02M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $2.02M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $2.02M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.96M 10-K · filed 2025-03-26 |
| 2024-09-30 | $1.96M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $1.96M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $1.96M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $1.89M 10-K · filed 2024-03-27 |
| 2023-09-30 | $1.08M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $2.11M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $1.59M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $2.32M 10-K · filed 2023-03-09 |
| 2022-09-30 | $2.32M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $2.32M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $2.32M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $2.26M 10-K · filed 2022-03-15 |
| 2021-09-30 | $2.77M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $2.77M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $2.77M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $2.69M 10-K · filed 2021-03-18 |
| 2020-09-30 | $2.69M 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |